Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q2 2025 Earnings
ALNY
1
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.07
-0.75
-0.44
-0.13
Details
Expected EPS
-0.890018
Actual EPS
-0.44
Surprise EPS
0.45
Surprise Percent
+50.56%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.44 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist